Trial Registration and Declaration of Registration by Authors of Randomized Controlled Trials

被引:27
作者
McGee, Richard G. [1 ,2 ,3 ]
Su, Michael [3 ]
Kelly, Patrick J. [3 ]
Higgins, Gail Y. [1 ,2 ]
Craig, Jonathan C. [1 ,2 ,3 ]
Webster, Angela C. [1 ,2 ,3 ,4 ]
机构
[1] Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW, Australia
[2] Childrens Hosp Westmead, Cochrane Renal Grp, Westmead, NSW, Australia
[3] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
[4] Westmead Hosp, Ctr Transplant & Renal Res, Westmead, NSW 2145, Australia
基金
英国医学研究理事会;
关键词
Trial registration; Registration declaration; Cohort study; Kidney transplantation; PUBLICATION BIAS; CLINICAL-TRIALS; ASSOCIATION; CONCLUSIONS; STATEMENT;
D O I
10.1097/TP.0b013e318232baf2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Trial registration was introduced to reduce research bias by promoting trial transparency and accountability. We aimed to evaluate the frequency of, and factors associated with, trial registration and declaration of trial registration. Methods. We selected all randomized controlled trials in kidney transplantation published between October 2005 and December 2010 and determined whether a trial was registered and whether a trial declared their registration in subsequent trial reports. Results. Of 307 eligible trials identified, 24% (74/307) were registered, and of those, 59% (44/74) contained trial registration details within at least one trial report. Trial registration was more likely for trials published more than once, in later years or reported in journals that followed the International Committee of Medical Journal Editors guidelines. Trial registration was less likely for trials that did not declare their funding sources. Registered trials were more likely to declare registration details in related reports if published in later years or in a journal that followed International Committee of Medical Journal Editors guidelines. Trials that did not declare their funding sources were less likely to declare registration details. Conclusions. Although still suboptimal, the situation is improving over time, with both trial registration and declaration of registration details more likely in later years.
引用
收藏
页码:1094 / 1100
页数:7
相关论文
共 31 条
  • [1] Association of funding and conclusions in randomized drug trials - A reflection of treatment effect or adverse events?
    Als-Nielsen, B
    Chen, WD
    Gluud, C
    Kjaergard, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07): : 921 - 928
  • [2] [Anonymous], 2007, ANN SURG, V245, P505
  • [3] [Anonymous], BMJ
  • [4] [Anonymous], 2008, Multilevel and Longitudinal Modeling Using Stata, DOI DOI 10.1093/GERONI/IGZ038.1816
  • [5] Bhandari M, 2004, CAN MED ASSOC J, V170, P477
  • [6] Access to clinical trial data
    Chan, An-Wen
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [7] Chan AW, 2008, GERMAN J EVID QUAL S, V102, ps27
  • [8] THE EFFECT OF LORCAINIDE ON ARRHYTHMIAS AND SURVIVAL IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - AN EXAMPLE OF PUBLICATION BIAS
    COWLEY, AJ
    SKENE, A
    STAINER, K
    HAMPTON, JR
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1993, 40 (02) : 161 - 166
  • [9] Trials, tricks and transparency: How disclosure rules affect clinical knowledge
    Dahm, Matthias
    Gonzalez, Paula
    Porteiro, Nicolas
    [J]. JOURNAL OF HEALTH ECONOMICS, 2009, 28 (06) : 1141 - 1153
  • [10] Clinical trial registration - A statement from the International Committee of Medical Journal editors
    De Angelis, C
    Drazen, JM
    Frizelle, FA
    Haug, C
    Hoey, J
    Horton, R
    Kotzin, S
    Laine, C
    Marusic, A
    Overbeke, AJPM
    Schroeder, TV
    Sox, HC
    Van der Weyden, MB
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (06) : 293 - 294